Literature DB >> 23592004

Time for a revision on the role of PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatment for patients with metastatic hormone-refractory prostate cancer.

Giandomenico Roviello1, Roberto Petrioli, Edoardo Francini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23592004     DOI： 10.5301/jbm.5000019

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN： 0393-6155            Impact factor:   2.659


× No keyword cloud information.
  1 in total

Review 1.  PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials.

Authors:  Edoardo Francini; Roberto Petrioli; Giulia Rossi; Letizia Laera; Giandomenico Roviello
Journal:  Tumour Biol       Date:  2014-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.